Financhill
Back

Summit Therapeutics Quote, Financials, Valuation and Earnings

Summit Therapeutics Price Quote

$18.40
-0.14 (-0.76%)
(Updated: December 9, 2024 at 11:50 AM ET)

Summit Therapeutics Key Stats

Buy
64
Summit Therapeutics (SMMT) is a Buy

Day range:
$17.61 - $19.30
52-week range:
$2.05 - $33.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13,758.73
P/B ratio:
31.22%

Volume:
2.2M
Avg. volume:
2.1M
1-year change:
662.96%
Market cap:
$13.7B
Revenue:
$0
EPS:
$-0.24

How Much Does Summit Therapeutics Make?

Data Unavailable

Is Summit Therapeutics Growing As A Company?

Data Unavailable

Summit Therapeutics Stock Price Performance

What Is Summit Therapeutics 52-Week High & Low?

Summit Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Summit Therapeutics?

Is Summit Therapeutics Cash Flow Positive?

  • What Is SMMT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$112.9M
  • What Is Summit Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $411.1M
  • What Is Summit Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$228.3M

Summit Therapeutics Return On Invested Capital

Data Unavailable

Summit Therapeutics Earnings Date & Stock Price

Summit Therapeutics Competitors

Summit Therapeutics Dividend Yield

Summit Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -19.41%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 33.64
Upside from Last Price: 81.44%

Major Shareholders

  • How many SMMT shares are owned by institutional investors?
    111.5M SMMT shares are owned by institutional investors
  • How many SMMT shares are owned by insiders?
    142.7M SMMT shares are owned by insiders